PLUS1
5.89
-0.41 (-6.51%)
-0.41 (-6.51%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 138,932 |
|
|||||
| News | (2) | ||||||
| Day High | 6.29 | Low High |
|||||
| Day Low | 5.71 | ||||||
Best deals to access real time data! |
|
USA Big Cap Pro
Monthly Subscription
for only
|
|
USA Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime USA (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Stock Name | Stock Symbol | Market | Stock Type |
|---|---|---|---|
| Aptevo Therapeutics Inc | APVO | NASDAQ | Common Stock |
| Price Change | Price Change % | Stock Price | Last Trade
 |
|
|---|---|---|---|---|
| -0.41 | -6.51% | 5.89 | 12:00:01 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 6.04 | 5.71 | 6.29 | 5.89 | 6.30 |
| Trades | Stocks Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 855 | 138,932 | US$ 5.97 | US$ 829,492 | - | 5.71 - 43.21 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 11:59:00 | 1 | US$ 5.61 | USD |
Period:
Draw Mode:
Aptevo Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 28.85M | 4.90M | 2.88M | US$ 4.31M | US$ - | -5.23 | -1.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | US$ - | - | -1.64M | 24.10% |
Aptevo Therapeutics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 22/1/2022 | 00:16 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 22/1/2022 | 00:15 | Seeking Alpha | Aptevo Therapeutics Board Chairman Fuad El-Hibri to retire |
| 24/11/2021 | 00:31 | Seeking Alpha | Aptevo stock nearly doubles after APVO436 + chemotherapy.. |
| 24/11/2021 | 00:19 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 23/11/2021 | 09:29 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) |
| 13/11/2021 | 00:30 | Seeking Alpha | Aptevo Therapeutics EPS beats by $0.03, misses on revenue |
| 13/11/2021 | 00:17 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 13/11/2021 | 00:12 | Edgar (US Regulatory) | Quarterly Report (10-q) |
| 06/11/2021 | 07:16 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 03/11/2021 | 00:00 | GlobeNewswire Inc. | BriaCell Appoints Renowned Pharmaceutical Veteran Jane.. |
| 27/8/2021 | 23:01 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 20/8/2021 | 20:04 | Edgar (US Regulatory) | Notice of Effectiveness (effect) |
Historical APVO Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 6.95 | 7.24 | 5.71 | 6.68 | 79,354 | -1.06 | -15.25% |
| 1 Month | 7.80 | 8.5495 | 5.71 | 7.54 | 128,122 | -1.91 | -24.49% |
| 3 Months | 15.16 | 22.0799 | 5.71 | 15.44 | 3,858,102 | -9.27 | -61.15% |
| 6 Months | 20.95 | 22.0799 | 5.71 | 15.46 | 1,743,436 | -15.06 | -71.89% |
| 1 Year | 31.21 | 43.21 | 5.71 | 15.93 | 908,031 | -25.32 | -81.13% |
| 3 Years | 1.60 | 60.00 | 0.195 | 11.43 | 750,087 | 4.29 | 268.13% |
| 5 Years | 2.32 | 60.00 | 0.195 | 9.98 | 545,482 | 3.57 | 153.88% |
